We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
476
Scotia Capital
Ontario, Canada
$17.6M -$1.59M -2,983 -8%
AWM
477
AE Wealth Management
Kansas
$17.4M +$981K +1,841 +6%
VIM
478
Vancity Investment Management
British Columbia, Canada
$17.3M +$7.38M +13,855 +68%
ZIM
479
Zacks Investment Management
Illinois
$17.1M +$398K +746 +2%
AIM
480
Arcadia Investment Management
Michigan
$16.9M +$266K +500 +2%
MKC
481
M. Kraus & Co
Vermont
$16.8M +$60.2K +113 +0.3%
TBA
482
Tower Bridge Advisors
Pennsylvania
$16.7M +$82.6K +155 +0.5%
Jones Financial Companies
483
Jones Financial Companies
Missouri
$16.7M -$471K -884 -3%
HCMT
484
Highland Capital Management (Tennessee)
Tennessee
$16.6M -$444K -834 -2%
CAM
485
Cresset Asset Management
Illinois
$16.6M +$571K +1,071 +3%
SPIA
486
Steward Partners Investment Advisory
New York
$16.6M +$388K +729 +2%
LIM
487
Lathrop Investment Management
Arkansas
$16.5M -$61.3K -115 -0.4%
RMA
488
Roffman Miller Associates
Pennsylvania
$16.5M +$282K +530 +2%
DILIC
489
Dai-ichi Life Insurance Company
Japan
$16.5M +$4.53M +8,497 +35%
KRS
490
Kentucky Retirement Systems
Kentucky
$16.4M +$783K +1,469 +5%
EMPI
491
Elo Mutual Pension Insurance
Finland
$16.3M +$289K +543 +2%
SS
492
Simplicity Solutions
Minnesota
$16.2M +$2.24M +4,198 +15%
HA
493
HHLR Advisors
Cayman Islands
$16.2M -$5.06M -9,500 -23%
BVDMP
494
Bedrijfstakpensioenfonds Voor De Media PNO
Netherlands
$16.1M
OC
495
Oppenheimer & Co
New York
$16.1M -$520K -975 -3%
BFG
496
Bleakley Financial Group
New Jersey
$16M +$1.98M +3,713 +13%
N
497
Natixis
France
$16M -$4.36M -8,174 -21%
LG
498
LaFleur & Godfrey
Michigan
$15.9M -$89.5K -168 -0.5%
BB
499
Busey Bank
Illinois
$15.8M +$326K +612 +2%
MIG
500
McGuire Investment Group
Rhode Island
$15.7M +$386K +725 +2%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.